-

SHAREHOLDER ALERT: Robbins LLP Investigates View, Inc. (VIEW) f/k/a CF Finance Acquisition Corp. II on Behalf of Shareholders

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP is investigating View, Inc. (NASDAQ: VIEW) to determine whether certain View officers and directors violated securities laws and breached their fiduciary duties to the Company. View manufactures smart building products that are purportedly designed to improve people's health, productivity, and experience while reducing energy consumption. Its primary product is a proprietary electrochromic glass panel that intelligently adjusts in response to the sun by tinting from clear to dark states, reducing heat and glare.

For more information about View, Inc.'s misconduct, click here.

View, Inc. (VIEW) May Have Misrepresented its Previously Disclosed Warranty Accruals

On November 30, 2020, CF Finance Acquisition Corp. II and View announced they had entered into a definitive merger agreement. On March 8, 2021, CF Finance Acquisition Corp. II and View combined via a business combination with View as the surviving public entity.

According to a class action complaint filed on behalf of purchasers of View, between November 30, 2020 and August 16, 2021, View stated that it had recorded a one-time warranty accrual of $24.5 million during the nine months ended September 30, 2019. On August 16, 2021, View announced it "began an independent investigation concerning the adequacy of the company's previously disclosed warranty accrual." On this news, the Company's share price fell $1.26, or over 24%, to close at $3.92 per share on August 17, 2021.

It appears that View had not properly accrued warranty costs related to its product and that there was a material weakness in View’s internal controls over accounting and financial reporting related to warranty accrual. As a result, View misstated its financial results.

View, Inc. (VIEW) shareholders have legal options. If you own shares of View, Inc. contact us for more information. All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

Contact us to learn more:
Aaron Dumas
(800) 350-6003
adumas@robbinsllp.com
Shareholder Information Form

About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. To be notified if a class action against View, Inc. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Aaron Dumas
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

Robbins LLP Informs Stockholders it is Investigating Potential Securities Claims Involving Wealthfront Corporation

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP is investigating Wealthfront Corporation (NASDAQ: WLTH) to determine whether certain Wealthfront officers and directors violated securities laws and breached fiduciary duties to shareholders.Why Are We Investigating Wealthfront?Wealthfront completed its initial public offering in December 2025, offering 34,615,384 shares of common stock at $14.00 per share, including shares sold by the Company and selling stockholders. The Compa...

Robbins LLP Informs Stockholders It Is Investigating Potential Securities Claims Involving Hyliion Holdings Corp.

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP is investigating Hyliion Holdings Corp. (AMEX: HYLN) to determine whether certain Hyliion Holdings officers and directors violated securities laws and breached fiduciary duties to shareholders. Hyliion is a power generator company whose primary product is the KARNQ Power Module.Why Are We Investigating Hyliion Holdings?Hyliion stock dropped 16% on Tuesday, June 23, 2026, following the release of a short-seller report from Pelica...

Robbins LLP Urges CAPR Stockholders to Contact the Firm for Information About the Class Action Against Capricor Therapeutics, Inc.

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs investors that a securities class action has been filed on behalf of all persons and entities that purchased or otherwise acquired Capricor Therapeutics, Inc. (NASDAQ: CAPR) securities between December 17, 2025 and July 26, 2026 (the "Class Period").The lawsuit alleges that Capricor Therapeutics misled investors regarding the path to FDA approval for its lead product candidate Deramiocel, a cell therapy to address cardiac and skeletal muscle compli...
Back to Newsroom